Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-05-22
Original SEC Filing: Click here

---

Webplus: SVA/20200522/6-K/2_EX-99.1/000.htm SEC Original: tm2020769d1_ex99-1.htm
Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development BEIJING, May 22, 2020 — (BUSINESS WIRE) — Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a transaction in which Advantech Capital and Vivo Capital have invested $15 million in Sinovac Research and Development Co., Ltd. (“Sinovac R&D”),

---

---

Webplus: SVA/20200522/6-K/1/000.htm SEC Original: tm2020769-1_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-05-22CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200